Novo Resources Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Novo Resources Provides Business Update

Novo Nordisk Q3 preview: UBS eyes 2027 exit rate as Ozempic declines

November 3, 2026 6:00 PM EST

UBS expects Novo Nordisk (NYSE: NVO) third-quarter results before the open on Wednesday to come in line with consensus on sales, with the bank expecting attention to shift to the drugmakers growth trajectory heading into 2027.

Analysts expect revenue of 73.79 billion Danish kroner and EPS of 4.62 kroner. Novo shares are down 21.4% year to date and 17.9%... More